166 related articles for article (PubMed ID: 32299194)
1. The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability.
Lee YJ; Lee EY; Choi BH; Jang H; Myung JK; You HJ
Mol Cells; 2020 May; 43(5):459-468. PubMed ID: 32299194
[TBL] [Abstract][Full Text] [Related]
2. microRNA-192 suppresses the expression of the farnesoid X receptor.
Krattinger R; Boström A; Schiöth HB; Thasler WE; Mwinyi J; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1044-51. PubMed ID: 27079614
[TBL] [Abstract][Full Text] [Related]
3. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
[TBL] [Abstract][Full Text] [Related]
4. FXR silencing in human colon cancer by DNA methylation and KRAS signaling.
Bailey AM; Zhan L; Maru D; Shureiqi I; Pickering CR; Kiriakova G; Izzo J; He N; Wei C; Baladandayuthapani V; Liang H; Kopetz S; Powis G; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G48-58. PubMed ID: 24177031
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
Sipos F; Firneisz G; Műzes G
World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells.
Selmin OI; Fang C; Lyon AM; Doetschman TC; Thompson PA; Martinez JD; Smith JW; Lance PM; Romagnolo DF
J Nutr; 2016 Feb; 146(2):236-42. PubMed ID: 26609171
[TBL] [Abstract][Full Text] [Related]
7. Depletion of c-Myc inhibits human colon cancer colo 320 cells' growth.
Hongxing Z; Nancai Y; Wen S; Guofu H; Yanxia W; Hanju H; Qian L; Wei M; Yandong Y; Hao H
Cancer Biother Radiopharm; 2008 Apr; 23(2):229-37. PubMed ID: 18454692
[TBL] [Abstract][Full Text] [Related]
8. WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
Yokota K; Tanaka Y; Harada H; Kaida T; Nakamoto S; Soeno T; Fujiyama Y; Yokota M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
Ann Surg Oncol; 2019 Dec; 26(13):4826-4834. PubMed ID: 31549316
[TBL] [Abstract][Full Text] [Related]
9. Momordin Ic induces G0/1 phase arrest and apoptosis in colon cancer cells by suppressing SENP1/c-MYC signaling pathway.
Xianjun F; Xirui X; Jie T; Huiwen M; Shaojun Z; Qiaoyun L; Yunxin L; Xuqun S
J Pharmacol Sci; 2021 Aug; 146(4):249-258. PubMed ID: 34049792
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2/STAT3 signalling via transactivation of SOCS3 gene.
Li S; Xu Z; Guo J; Zheng J; Sun X; Yu J
J Cell Mol Med; 2020 Dec; 24(24):14549-14560. PubMed ID: 33164339
[TBL] [Abstract][Full Text] [Related]
11. RNF8 induces β-catenin-mediated c-Myc expression and promotes colon cancer proliferation.
Ren L; Zhou T; Wang Y; Wu Y; Xu H; Liu J; Dong X; Yi F; Guo Q; Wang Z; Li X; Bai N; Guo W; Guo M; Jiang B; Wu X; Feng Y; Song X; Zhang S; Zhao Y; Cao L; Han S; Xing C
Int J Biol Sci; 2020; 16(12):2051-2062. PubMed ID: 32549753
[TBL] [Abstract][Full Text] [Related]
12. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression.
Zhan W; Liao X; Wang Y; Li L; Li J; Chen Z; Tian T; He J
Carcinogenesis; 2019 Jun; 40(4):560-568. PubMed ID: 30403769
[TBL] [Abstract][Full Text] [Related]
13. Stress-induced cleavage of Myc promotes cancer cell survival.
Conacci-Sorrell M; Ngouenet C; Anderson S; Brabletz T; Eisenman RN
Genes Dev; 2014 Apr; 28(7):689-707. PubMed ID: 24696454
[TBL] [Abstract][Full Text] [Related]
14. ERRα metabolic nuclear receptor controls growth of colon cancer cells.
Bernatchez G; Giroux V; Lassalle T; Carpentier AC; Rivard N; Carrier JC
Carcinogenesis; 2013 Oct; 34(10):2253-61. PubMed ID: 23720198
[TBL] [Abstract][Full Text] [Related]
15. Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention.
Zeng H; Hamlin SK; Safratowich BD; Cheng WH; Johnson LK
Nutr Res; 2020 Nov; 83():63-72. PubMed ID: 33017771
[TBL] [Abstract][Full Text] [Related]
16. High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.
Kim HB; Kim MJ; Kim DY; Lee JW; Bae JH; Kim DW; Kang CD; Kim SH
Mol Cancer; 2011 Apr; 10():46. PubMed ID: 21513580
[TBL] [Abstract][Full Text] [Related]
17. DPEP1 promotes the proliferation of colon cancer cells via the DPEP1/MYC feedback loop regulation.
Liu Q; Deng J; Yang C; Wang Y; Shen Y; Zhang H; Ding Z; Zeng C; Hou Y; Lu W; Jin J
Biochem Biophys Res Commun; 2020 Nov; 532(4):520-527. PubMed ID: 32896379
[TBL] [Abstract][Full Text] [Related]
18. Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand.
Yu J; Yang K; Zheng J; Zhao W; Sun X
Cancer Gene Ther; 2021 Jun; 28(6):590-601. PubMed ID: 33046820
[TBL] [Abstract][Full Text] [Related]
19. ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.
Huang WS; Wang JP; Wang T; Fang JY; Lan P; Ma JP
World J Gastroenterol; 2007 Dec; 13(48):6581-7. PubMed ID: 18161931
[TBL] [Abstract][Full Text] [Related]
20. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
Xu H; Li J; Chen H; Ghishan FK
Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
